Shares
Creating value with biosimilars
With the commercialization of the next approved biosimilar assets and the continuous expansion of its own development pipeline, Formycon has its sights set on growth and sustainable profitability.
Formycon AG
Share Chart
Basic
Information
| Legal Form | German Stock Corporation (Aktiengesellschaft) |
| Initial Exchange Listing | December 20, 2010 |
| ISIN | DE000A1EWVY8 |
| WKN | A1EWVY |
| Exchange and Market Segment | Regulated Market (Prime Standard) SDAX, TecDAX |
| Trading Venues | Xetra, Berlin, Düsseldorf, Frankfurt, Hamburg, Munich, Stuttgart, Tradegate |
| Share Type | Bearer shares without par value |
| Registered Capital | EUR 17,664,427.00 |
| Shares Outstanding | 17,664,427 Bearer shares |
| Designated Sponsors | Oddo BHF Corporates & Markets AG M.M. Warburg & Co |
Shareholder
Structure
Structure as of November 11, 2024
This overview reflects the voting rights notifications pursuant to §§ 33ff of the German Securities Trading Act (Wertpapierhandelsgesetz – WpHG). The individual notifications can be found here.
Analyst
Ratings
| Analyst | Recommendation | Target price in € | Date of latest Research Report |
|---|---|---|---|
| Berenberg | buy | 42,0 | 02/19/2025 |
| First Berlin | buy | 46,0 | 02/24/2024 |
| Hauck & Aufhäuser | buy | 49,0 | 03/04/2025 |
| H.C. Wainwright | buy | 57,0 | 03/10/2025 |
| Jefferies | Under review | 86,0 | 11/28/2024 |
| Kepler Cheuvreux | buy | 50,0 | 02/21/2025 |
| B. Metzler seel. Sohn & Co. | buy | 52,0 | 02/20/2025 |
| mwb [→ Research Formycon AG] | buy | 62,0 | 02/18/2025 |
| Oddo BHF | Neutral | 38,0 | 02/18/2025 |
| Royal Bank of Canada | Outperform | 51,0 | 02/18/2025 |
| M.M. Warburg & Co | buy | 56,0 | 02/18/2025 |
| Average Target Price | 54,0 | 03/10/2025 |
Formycon is covered and evaluated by the analysts mentioned above. Please note that any opinions, estimates or forecasts regarding Formycon’s performance made by these analysts are theirs alone and do not represent opinions, estimates or forecasts of Formycon or its management. The above reference to the analysts does not imply that Formycon endorses their opinions. Formycon is under no obligation to update or supplement the information provided above and does not guarantee the accuracy or completeness of this list.
Analysten Consensus
â– Â 24,05 % Santo Holding (Deutschland) GmbH, Thomas Peter Maier
â– Â Â 13,26 % Wpart GmbH, Wen.Co Invest GmbH, Peter Wendeln
■ 9,08 % Richter Gedeon Vegyészeti Gyár Nyilvánosan Müködö Rt. (Gedeon Richter)
■ 6,04 % Active Ownership Fund SICAV SIF SCS, Klaus Röhrig, Florian Schuhbauer
■ 5,10 % Detlef und Ursula Spruth
■ 3,28 % Stefan Reichensperger
â– Â 39,19 % Streubesitz